tetanus toxoid

tetanus toxoid

tetanus toxoid n.

tetanus toxoid n.

tetanus toxoid n.

Tetanus toxoid immunization to reduce mortality from neonatal tetanus

Experience with Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine in Japan

Functional Antibodies Elicited by an 11-Valent Diphtheria-Tetanus Toxoid-Conjugated Pneumococcal Vaccine

Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection

Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali

Diphtheria Antitoxin Levels among Children Primed with a Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Lot with a Subpotent Diphtheria Toxoid Component

Lymphocyte Response to Tetanus Toxoid among Indonesian Men Immunized with Tetanus-Diphtheria during Extended Chloroquine or Primaquine Prophylaxis

Decreased Point Prevalence of Haemophilus influenzae Type b (Hib) Oropharyngeal Colonization by Mass Immunization of Brazilian Children Less Than 5 Years Old with Hib Polyribosylribitol Phosphate Polysaccharide—Tetanus Toxoid Conjugate Vaccine in Combination with Diphtheria-Tetanus Toxoids—Pertussis Vaccine

Safety and Immunogenicity of Haemophilus influenzae-Tetanus Toxoid Conjugate Vaccine Given Separately or in Combination with a Three-Component Acellular Pertussis Vaccine Combined with Diphtheria and Tetanus Toxoids and Inactivated Poliovirus Vaccine for the First Four Doses

Evidence of Efficacy of the Lederle/Takeda Acellular Pertussis Component Diphtheria and Tetanus Toxoids and Pertussis Vaccine but Not the Lederle Whole-Cell Component Diphtheria and Tetanus Toxoids and Pertussis Vaccine Against Bordetella parapertussis Infection

Magnitude of Interference after Diphtheria-Tetanus Toxoids–Acellular Pertussis/Haemophilus influenzae Type b Capsular Polysaccharide–Tetanus Vaccination Is Related to the Number of Doses Administered

Serological characterization of anti-endotoxin serum directed against the conjugate of oligosaccharide core of Escherichia coli type R4 with tetanus toxoid

Safety and Immunogenicity of Capsular Polysaccharide—Tetanus Toxoid Conjugate Vaccines for Group B Streptococcal Types Ia and Ib

Use of Capsular Polysaccharide—Tetanus Toxoid Conjugate Vaccine for Type II Group B Streptococcus in Healthy Women

The Protein Content of Diphtheria-Tetanus Toxoids–Acellular Pertussis Vaccines and an Emerging Clinical Problem